According to Calcalist, the Israeli financial news website responsible for breaking the story, Soriot met with Teva's search committee and chairman to express his agreement. Its chief Erez Vigodman stepped down in February.
Abdelhak Nouri suffers 'permanent brain damage' after collapsing on the pitch
Nouri has been cleared to leave hospital in Innsbruck and will be transferred to Amsterdam in the coming days, Ajax said. Last season he was chosen as best player in the Jupiler League, where he played with Jong Ajax.
Is AstraZeneca PLC Chief Executive Pascal Soriot staying or going? Soriot, 58, has been running AstraZeneca since 2012, although the company has been struggling.
"While neither Teva nor AstraZeneca has confirmed, we can not dismiss the Calcalist article given the track record of the Israeli press and the detailed disclosure of the compensation package", said Baum in a note to clients this morning. Early results for a closely followed lung-cancer treatment are also expected within weeks.
The Duchess of Cambridge's masterclass in polished make-up
The tiara was a wedding gift to the late Princess Diana from the Queen, and was known to be one of her favourite pieces. Not to be outdone, the queen herself wore the Brazilian Aquamarine Tiara, studded with massive pale blue gemstones.
If the combination of durvalumab and tremelimumab works in the indication, AZ could market the therapy in an indication expected to be worth an estimated $20 billion in sales, where Merck & Co already has a foothold with its Keytruda (pembrolizumab). Reuters, however, also quoted UBS analysts as saying that they did not see a read across.
"That said, we have significant trouble reconciling the timing of the potential departure pre-MYSTIC and Dr Soriot's skill set match with Teva".
Still counting demonitised notes, says RBI Governor
The panel's meeting lasted for more than three hours and was attended by former Prime Minister Manmohan Singh, among others. More than six months post demonetisation but RBI has not disclosed the number of old currency notes in the central bank.
An AstraZeneca spokesperson declined to comment, describing the story as "rumour and speculation". "If Astra knew the results, they would have announced them".